当前位置:首页 - 行情中心 - 以岭药业(002603) - 财务分析 - 资产负债表

以岭药业

(002603)

  

流通市值:246.59亿  总市值:299.22亿
流通股本:13.77亿   总股本:16.71亿

资产负债表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
流动资产:
  货币资金1,034,428,553.181,040,200,332.521,003,161,043.02853,034,839.38
  交易性金融资产910,500,000560,500,000163,000,000-
  应收票据及应收账款1,380,240,603.451,399,916,419.191,607,442,791.611,225,430,236.42
        应收账款1,380,240,603.451,399,916,419.191,607,442,791.611,225,430,236.42
  应收款项融资374,360,367.33556,230,883.96463,374,984.89164,679,389.78
  预付款项77,707,069.7469,036,068.4495,626,980.1552,771,323.79
  其他应收款合计18,971,938.5517,753,554.1818,548,382.41129,849,796.08
  存货1,685,040,655.831,467,729,940.521,385,508,236.241,746,380,345.14
  其他流动资产58,343,157.9656,510,634.2657,705,915.88162,805,878.53
  流动资产合计5,539,592,346.045,167,877,833.074,794,368,334.24,334,951,809.12
非流动资产:
  长期股权投资2,462,266.52,465,332.812,467,765.172,470,541.6
  其他非流动金融资产---1,000,000
  投资性房地产55,370,232.956,362,432.3560,679,611.8162,556,648.77
  固定资产5,833,684,973.515,760,376,817.245,913,931,139.036,011,503,000.7
  在建工程1,127,468,826.461,280,505,676.531,186,954,728.841,196,940,326.89
  生产性生物资产22,873,720.2719,216,927.2717,277,514.3816,126,842.32
  使用权资产32,297,93034,446,729.526,724,476.7527,987,315.7
  无形资产785,320,608.36792,469,572.33795,474,567.54802,570,427.18
  开发支出323,166,756.35298,793,668.93270,129,783.3262,797,369.23
  商誉104,834,897.38106,394,079.39107,953,261.39109,512,443.4
  长期待摊费用3,264,025.763,031,351.724,471,713.034,080,492.2
  递延所得税资产307,687,897.66307,480,739.58385,172,702.92365,836,675.85
  其他非流动资产82,284,645.5169,891,952.03128,482,414.44120,837,195.32
  非流动资产合计8,680,716,780.668,731,435,279.688,899,719,678.68,984,219,279.16
  资产总计14,220,309,126.713,899,313,112.7513,694,088,012.813,319,171,088.28
流动负债:
  应付票据及应付账款1,806,027,938.061,766,367,878.661,892,620,893.361,896,575,493.59
  其中:应付票据7,186,965.583,257,394.68126,070,429.1850,000,000
        应付账款1,798,840,972.561,683,110,483.981,766,550,464.181,846,575,493.59
  合同负债342,081,666.78409,205,389.45360,256,470.39272,337,042.06
  应付职工薪酬182,908,329.92201,565,827.21249,092,045.2283,231,772.77
  应交税费109,279,715.2189,251,745.5786,940,808.1576,383,315.75
  其他应付款合计543,307,215.8541,001,874.9844,781,089.5748,476,089.14
        应付股利501,211,612.8---
  一年内到期的非流动负债9,854,865.389,746,542.927,759,330.78,238,049.29
  其他流动负债7,118,150.219,227,779.3619,702,442.2421,447,129.56
  流动负债合计3,000,577,881.412,526,367,038.152,661,153,079.612,606,688,892.16
非流动负债:
  租赁负债20,476,846.1221,795,589.219,088,455.4818,212,904.59
  递延收益390,919,643.33371,484,608.74374,960,088.28377,924,740.64
  递延所得税负债110,682,999.41112,390,754.22112,692,703.17114,251,885.18
  非流动负债合计522,079,488.86505,670,952.16506,741,246.93510,389,530.41
  负债合计3,522,657,370.273,032,037,990.313,167,894,326.543,117,078,422.57
所有者权益(或股东权益):
  实收资本(或股本)1,670,705,3761,670,705,3761,670,705,3761,670,705,376
  资本公积2,323,842,764.072,323,842,764.072,342,780,896.142,342,780,896.14
  其他综合收益-7,024,218.46-7,236,419.79-7,175,480.29-7,120,586.08
  盈余公积936,762,403.7936,762,403.7936,762,403.7936,762,403.7
  未分配利润5,779,552,701.625,948,894,667.245,606,312,938.765,280,359,642.51
  归属于母公司股东权益合计10,703,839,026.9310,872,968,791.2210,549,386,134.3110,223,487,732.27
  少数股东权益-6,187,270.5-5,693,668.78-23,192,448.05-21,395,066.56
  股东权益合计10,697,651,756.4310,867,275,122.4410,526,193,686.2610,202,092,665.71
  负债和股东权益合计14,220,309,126.713,899,313,112.7513,694,088,012.813,319,171,088.28
公告日期2025-10-282025-08-282025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑